Relative to recent successes in elucidating the genetic mechanisms associated with complex diseases, including macular degeneration, diabetes mellitus, type 2, heart disease, and cancer, molecular genetic approaches to psychiatric illness have met with more limited success. While factors such as small allelic effects, allelic heterogeneity, and variation in population substructure have received considerable attention in attempt to explain the paucity of significant results in psychiatric genetics, significantly less focus has been directed toward phenotypic factors.
Method:
Data derived from molecular genetic studies of the psychosis phenotype in patients with a range of psychiatric illnesses are reviewed.
Results:
Available data suggest that genes do not respect the boundaries of the current diagnostic system but may confer risk for symptom-based phenotypic variation that traverses those boundaries.
Conclusions:
Molecular genetic studies offer convincing evidence for a relation between genetic variation and symptom-based phenotypic variation within psychiatric illness. These data may provide novel insights into the pathophysiology of schizophrenia and other related disorders. The exploration of relations between genetic variation and symptom variation that traverses traditional diagnostic boundaries may ultimately lead to more refined classification systems that more closely reflect the genetic etiology of psychiatric illness.
CarpenterWTJrBuchananRWKirkpatrickB, Strong inference, theory testing, and the neuroanatomy of schizophrenia. Arch Gen Psychiatry. 1993;50(10):825–831.
2.
PotashJBWillourVLChiuYF, The familial aggregation of psychotic symptoms in bipolar disorder pedigrees. Am J Psychiatry. 2001;158(8):1258–1264.
3.
PotashJBZandiPPWillourVL, Suggestive linkage to chromosomal regions 13q31 and 22q12 in families with psychotic bipolar disorder. Am J Psychiatry. 2003;160(4):680–686.
4.
HametPMerloESedaO, Quantitative founder-effect analysis of French Canadian families identifies specific loci contributing to metabolic phenotypes of hypertension. Am J Hum Genet. 2005;76:815–832.
5.
PotashJBToolanJSteeleJ, The bipolar disorder phenome database: A resource for genetic studies. Am J Psychiatry. 2007;164(8):1229–1237.
6.
BerrettiniW.Susceptibility loci for bipolar disorder: Overlap with inherited vulnerability to schizophrenia. Biol Psychiatry. 2000;47(3):245–251.
7.
LaursenTMLabouriauRLichtRW, Family history of psychiatric illness as a risk factor for schizoaffective disorder: A Danish register-based cohort study. Arch Gen Psychiatry. 2005;62(8):841–848.
8.
KendlerKSGruenbergAMTsuangMT. Psychiatric illness in first-degree relatives of schizophrenic and surgical control patients. A family study using DSM-III criteria. Arch Gen Psychiatry. 1985;42(8):770–779.
9.
KendlerKSMcGuireMGruenbergAM, The Roscommon Family Study. IV. Affective illness, anxiety disorders, and alcoholism in relatives. Arch Gen Psychiatry. 1993;50(12): 952–960.
10.
Erlenmeyer-KimlingLAdamoUHRockD, The New York High-Risk Project. Prevalence and comorbidity of axis I disorders in offspring of schizophrenic parents at 25-year follow-up. Arch Gen Psychiatry. 1997;54(12):1096–1102.
11.
KendlerKSKarkowski-ShumanLO'NeillFA, Resemblance of psychotic symptoms and syndromes in affected sibling pairs from the Irish Study of High-Density Schizophrenia Families: Evidence for possible etiologic heterogeneity. Am J Psychiatry. 1997;154(2):191–198.
12.
LoftusJDelisiLECrowTJ. Factor structure and familiality of first-rank symptoms in sibling pairs with schizophrenia and schizoaffective disorder. Br J Psychiatry. 2000;177:15–19.
13.
CardnoAGJonesLAMurphyKC, Dimensions of psychosis in affected sibling pairs. Schizophr Bull. 1999;25(4):841–850.
14.
CardnoAGShamPCMurrayRM, Twin study of symptom dimensions in psychoses. Br J Psychiatry. 2001;179:39–45.
15.
RijsdijkFVGottesmanIIMcGuffinP, Heritability estimates for psychotic symptom dimensions in twins with psychotic disorders. Am J Med Genet B Neuropsychiatr Genet. 2010;156B(1):89–98.
16.
KrabbendamLIsusiPGaldosP, Associations between COMTVal158Met polymorphism and cognition: Direct or indirect effects?Eur Psychiatry. 2006;21(5):338–342.
17.
OwenMJCraddockNJablenskiA.The genetic deconstruction of psychosis. Schizophr Bull. 2007;33(4):905–911.
18.
WilliamsHJOwenMJO'DonovanMC. Schizophrenia genetics: New insights from new approaches. Br Med Bull. 2009;91:61–74.
19.
LewisCMLevinsonDFWiseLH, Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am J Hum Genet. 2003;73(1):34–48.
20.
PotashJB. Carving chaos: Genetics and the classification of mood and psychotic syndromes. Harv Rev Psychiatry. 2006;14(2):47–63.
21.
ParkNJuoSHChengR, Linkage analysis of psychosis in bipolar pedigrees suggests novel putative loci for bipolar disorder and shared susceptibility with schizophrenia. Mol Psychiatry. 2004;9(12):1091–1099.
22.
McGuffinPKnightJBreenG, Whole genome linkage scan of recurrent depressive disorder from the depression network study. Hum Mol Genet. 2005;14(22):3337–3345.
23.
FanousAHNealeMCGardnerCO, Significant correlation in linkage signals from genome-wide scans of schizophrenia and schizotypy. Mol Psychiatry. 2007;12(10):958–965.
24.
ChumakovIBlumenfeldMGuerassimenkoO, Genetic and physiologic data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Pro Natl Acad Sci USA. 2002;99(21):13675–13680.
25.
Detera-WadleighSDMcMahonFJ. G72/G30 in schizophrenia and bipolar disorder: Review and meta-analysis. Biol Psychiatry. 2006;60(2):106–114.
26.
MüllerDJZaiCCShinkaiT, Association between the DAOA/G72 gene and bipolar disorder and meta-analyses in bipolar disorder and schizophrenia. Bipolar Disord. 2011;13(2):198–207.
27.
SchumacherJJamraRAFreudenbergJ, Examination of G72 and D-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder. Mol Psychiatry. 2004;9(2):203–207.
28.
RietschelMBeckmannLStrohmaierJ, G72 and its association with major depression and neuroticism in large population-based groups from Germany. Am J Psychiatry. 2008;165(6):753–762.
29.
SchulzeTGOhlraunSCzerskiPM, Genotype-phenotype studies in bipolar disorder showing association between the DAOA/ G30 locus and persecutory delusions: A first step toward a molecular genetic classification of psychiatric phenotypes. Am J Psychiatry. 2005;162(11):2101–2108.
30.
WilliamsNMGreenEKMacgregorS, Variation at the DAOA/G30 locus influences susceptibility to major mood episodes but not psychosis in schizophrenia and bipolar disorder. Arch Gen Psychiatry. 2006;63(4):366–373.
31.
CorvinADonohoeGMcGheeK, D-amino acid oxidase (DAO) genotype and mood symptomatology in schizophrenia. 2007;426(2):97–100.
32.
StefanssonHSigurdssonESteinthorsdottirV, Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet. 2002;71(4):877–892.
33.
StefanssonHSarginsonJKongA, Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. Am J Hum Genet. 2003;72(1):83–87.
34.
WilliamsNMPreeceASpurlockG, Support for genetic variation in neuregulin 1 and susceptibility to schizophrenia. Mol Psychiatry. 2003;8(5):485–487.
35.
TosatoSDazzanPCollierD.Association between the neuregulin 1 gene and schizophrenia: A systematic review. Schizophr Bull. 2005;31(3):613–617.
36.
GreenEKRaybouldRMacgregorS, Operation of the schizophrenia susceptibility gene, neuregulin 1, across traditional diagnostic boundaries to increase risk for bipolar disorder. Arch Gen Psychiatry. 2005;62(6):642–648.
37.
WalkerRMChristoforouAThomsonPA, Association analysis of Neuregulin 1 candidate regions in schizophrenia and bipolar disorder. Neurosci Lett. 2010;478(1):9–13.
38.
GoesFSWillourVLZandiPP, Family-based association study of Neuregulin 1 with psychotic bipolar disorder. Am J Med Genet B Neuropsychiatr Genet. 2009;150B(5):693–702.
39.
StraubREJiangYMacLeanCJ, Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am J Hum Genet. 2002;71(2):337–348.
40.
AllenNCBagadeSMcQueenMB, Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: The SzGene database. Nat Genet. 2008;40(7):827–834.
41.
RaybouldRGreenEKMacGregorS, Bipolar disorder and polymorphisms in the dysbindin gene (DTNBP1). Biol Psychiatry. 2005;57(7):696–701.
42.
DomschkeKLawfordBYoungR, Dysbindin (DTNBP1)-a role in psychotic depression?J Psychiatry Res. 2011;45(5):588–595.
43.
TuretskyBICalkinsMELightGA, Neurophysiological endophenotypes of schizophrenia: The viability of selected candidate measures. Schizophr Bull. 2007;33(1):69–94.
44.
FanousAHvan den OordEJRileyBP, Relationship between a high-risk haplotype in the DTNBP1 (Dysbindin) gene and clinical features of schizophrenia. Am J Psychiatry. 2005;162:1824–1832.
45.
McGuffinPFarmerAHarveyI.A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. Arch Gen Psychiatry. 1991;48(8):764–770.
46.
DeRossePFunkeBBurdickKE, Dysbindin genotype and negative symptoms in schizophrenia. Am J Psychiatry. 2006;163(3):532–534.
47.
WessmanJPaunioTTuulio-HenrikssonA, Mixture model clustering of phenotype features reveals evidence for association of DTNBP1 to a specific subtype of schizophrenia. Biol Psychiatry. 2009;66(11):990–996.
48.
TosatoSRuggeriMBonettoC, Association study of dysbindin gene with clinical and outcome measures in a representative cohort of Italian schizophrenic patients. Am J Med Genet B Neuropsychiatr Genet. 2007;144(5):647–659.
49.
CorvinADonohoeGNangleJM, A dysbindin risk haplotype associated with less severe manic-type symptoms in psychosis. Neurosci Lett. 2008;431(2):146–149.
50.
WirgenesK VDjurovicSAgartzI, Dysbindin and d-amino-acid-oxidase gene polymorphisms associated with positive and negative symptoms in schizophrenia. Neuropsychobiology. 2009;60(1):31–36.
51.
RéthelyiJMBakkerSCPolgárP, Association study of NRG1, DTNBP1, RGS4, G72/G30, and PIP5K2A with schizophrenia and symptom severity in a Hungarian sample. Am J Med Genet B Neuropsychiatr Genet. 2010;153B(3):792–801.
52.
St ClairDBlackwoodDMuirW, Association within a family of a balanced autosomal translocation with major mental-illness. Lancet. 1990;336:13–16.
53.
EkelundJHovattaIParkerA, Chromosome 1 loci in Finnish schizophrenia families. Hum Mol Genet. 2001;10(15):1611–1617.
54.
EkelundJHennahWHiekkalinnaT, Replication of 1q42 linkage in Finnish schizophrenia pedigrees. Mol Psychiatry. 2004;9(11):1037–1041.
55.
HamshereMLBennettPWilliamsN, Genomewide linkage scan in schizoaffective disorder: Significant evidence for linkage at 1q42 close to DISC1, and suggestive evidence at 22q11 and 19q13. Arch Gen Psychiatry. 2005;62(10):1081–1088.
56.
HennahWVariloTKestilaM, Haplotype transmission analysis provides evidence of association for DISC1 to schizophrenia and suggests sex-dependent effects. Hum Mol Genet. 2003;12(23):3151–3159.
57.
ThomsonPAHarrisSEStarrJM, Association between genotype at an exonic SNP in DISC1 and normal cognitive aging. Neurosci Lett. 2005;389(1):41–45.
58.
HodgkinsonCAGoldmanDJaegerJ, Disrupted in schizophrenia 1 (DISC1): Association with schizophrenia, schizoaffective disorder, and bipolar disorder. Am J Hum Genet. 2004;75:862–872.
59.
DeRossePHodgkinsonCALenczT, Disrupted in schizophrenia 1 genotype and positive symptoms in schizophrenia. Biol Psychiatry. 2007;61:1208–1210.
60.
TomppoLHennahWMiettunenJ, Association of variants in DISC1 with psychosis-related traits in a large population cohort. Arch Gen Psychiatry. 2009;66(2):134–141.
61.
FunkeBMalhotraAKFinnCT, COMT genetic variation confers risk for psychotic and affective disorders: A case control study. Behav Brain Funct. 2005;1:19.
62.
ShifmanSBronsteinMSternfeldM, A highly significant association between a COMT haplotype and schizophrenia. Am J Hum Genet. 2002;7(6):1296–1302.
63.
ShifmanSBronsteinMSternfeldM, COMT: A common susceptibility gene in bipolar disorder and schizophrenia. Am J Med Genet B. 2004;128(1)61–64.
64.
DeRossePHodgkinsonCALenczT, Disrupted in schizophrenia 1 genotype and positive symptoms in schizophrenia. Biol Psychiatry. 2007;61:1208–1210.
65.
GoghariVMSponheimSR. Differential association of the COMT Val158Met polymorphism with clinical phenotypes in schizophrenia and bipolar disorder. Schizophr Res. 2008;103(1–3):186–191.
66.
BenedettiFDallaspeziaSLocatelliC, Recurrence of bipolar mania is associated with catechol-O-methyltransferase Val(108/158)Met polymorphism. J Affect Disord. 2011;132(1–2):293–296.
67.
StefanisNCVan OsJAvramopoulosD, Variation in catechol-o-methyltransferase val158met genotype associated with schizotypy but not cognition: A population study in 543 young men. Biol Psychiatry. 2004;56(7):510–515.
68.
RaineA.The Schizotypal Personality Questionnaire (SPQ): A measure of schizotypal personality based on DSM-III-R criteria. Schizophr Bull. 1991;17:555–564.
69.
SmyrnisNAvramopoulosDEvdokimidisI, Effect of schizotypy on cognitive performance and its tuning by COMT val158met genotype variations in a large population of young men. Biol Psychiatry. 2007;61(7):845–853.
70.
AvramopoulosDStefanisNCHantoumiI, Higher scores of self reported schizotypy in healthy young males carrying the COMT high activity allele. Mol Psychiatry. 2002;7(7):706–711.
71.
SchürhoffFSzökeAChevalierF, Schizotypal dimensions: An intermediate phenotype associated with the COMT high activity allele. Am J Med Genet B Neuropsychiatr Genet. 2007;144B(1):64–68.
72.
van WinkelRIsusiPGaldosP, Evidence that the COMTVal158Met polymorphism moderates subclinical psychotic and affective symptoms in unaffected first-degree relatives of patients with schizophrenia. Eur Psychiatry. 2008;23(3):219–222.
73.
FanousAHNealeMCStraubRE, Clinical features of psychotic disorders and polymorphisms in HT2A, DRD2, DRD4, SLC6A3, (DAT1), and BDNF: A family based association study. Am J Med Genet B Neuropsychiatr Genet. 2004;125B(1):69–78.
74.
CardnoAGBowenTGuyCA, CAG repeat length in the hKCa3 gene and symptom dimensions in schizophrenia. Biol Psychiatry. 1999;45(12):1592–1596.
75.
SerrettiALilliRLorenziC, DRD4 exon 3 variants associated with delusional symptomatology in major psychoses: A study on 2,011 affected subjects. Am J Med Genet. 2001;105(3):283–290.
76.
SerrettiALattuadaELorenziC, Dopamine receptor D2 Ser/ Cys 311 variant is associated with delusion and disorganization symptomatology in major psychoses. Mol Psychiatry. 2000;5(3):270–274.
77.
ZhangXYZhouDFZhangPY, The CCK-A receptor gene possibly associated with positive symptoms of schizophrenia. Mol Psychiatry. 2000;5(3):239–240.
78.
MalhotraAKGoldmanDMazzantiC, A functional serotonin transporter (5-HTT) polymorphism is associated with psychosis in neuroleptic-free schizophrenics. Mol Psychiatry. 1998;3(4):328–332.
79.
FanousAHKendlerKS. Genetic heterogeneity, modifier genes, and quantitative phenotypes in psychiatric illness: Searching for a framework. Mol Psychiatry. 2005;10(1):6–13.
80.
BrzustowiczLMHonerWGChowEW, Use of a quantitative trait to map a locus associated with severity of positive symptoms in familial schizophrenia to chromosome 6p. Am J Hum Genet. 1997;61(6):1388–1396.
81.
WilcoxMAFaraoneSVSuJ, Genome scan of three quantitative traits in schizophrenia pedigrees. Biol Psychiatry. 2002;52(9):847–854.
82.
KendlerKSMyersJMO'NeillFA, Clinical features of schizophrenia and linkage to chromosomes 5q, 6p, 8p, and 10p in the Irish Study of High-Density Schizophrenia Families. Am J Psychiatry. 2000;157(3):402–408.
83.
DeRossePLenczTBurdickKE, The genetics of symptom-based phenotypes: Towards a molecular classification of schizophrenia. Schizophr Bull. 2008;34(6):1047–1053.
84.
WilliamsHJCraddockNRussoG, Most genome-wide significant susceptibility loci for schizophrenia and bipolar disorder reported to date cross-traditional diagnostic boundaries. Hum Mol Genet. 2011;20(2):387–391.
85.
RipkeSSandersARKendlerKS, Genome-wide association study identifies five new schizophrenia loci. Nat Genet. 2011;43(10):969–976.
86.
PurcellSMWrayNRStoneJL, Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature. 2009;460:748–752.
87.
HamshereMLO'DonovanMCJonesIR, Polygenic dissection of the bipolar phenotype. Br J Psychiatry. 2011;198:284–248.
